Cornea/External Disease News

WAIKOLOA, Hawaii — In this video from Hawaiian Eye 2022, Bobak Azamien, MD, PhD, president and CEO of Tarsus Pharmaceuticals, discussed the company’s plans to move TP-03 toward FDA approval.

WAIKOLOA, Hawaii — When it comes to the intraoperative management of ocular hemorrhage during DMEK or other corneal surgeries the most important first step is not to panic, a presenter said here in a case presentation.

WAIKOLOA, Hawaii — At Hawaiian Eye 2022, Audrey Talley Rostov, MD, discusses a lamellar keratoplasty technique for granular dystrophy she has performed using the Visumax femtosecond laser.

WAIKOLOA, Hawaii — Streamlined ocular surface evaluations in patients with dry eye disease can provide key information about eye health that may determine surgical outcomes, according to a presenter here.

WAIKOLOA, Hawaii — Preeya K. Gupta, MD, founder and director of Triangle Eye Consultants in Durham, North Carolina, discussed ocular surface disease at Hawaiian Eye 2022.

WAIKOLOA, Hawaii — Wendy W. Lee, MD, MS, professor of clinical ophthalmology at the University of Miami, helmed a discussion on identifying the differences in benign and malignant lesions on the eyelid here at the Hawaiian Eye meeting.

Happy New Year! Yes, I know that it has been almost a month since New Year’s Eve, but I missed seeing you that night. What kind of a friend would I be if I never gave you a New Year’s salutation, however tardy?

Enrollment is underway in two phase 2 clinical trials for dry eye disease and presbyopia, according to press releases from Glaukos.

The FDA has cleared an investigational new drug application for A197, which is being evaluated for the treatment of dry eye disease, according to a press release from Aramis Biosciences.

An exploration of the expanding roster of dry eye disease therapies and a video perspective detailing corneal cross-linking led coverage from the American Academy of Ophthalmology meeting in New Orleans.